Nasjonalt register for ny og kostbar behandling

Tidsskrift for den Norske Laegeforening

Volumn 128, Issue 15, 2008, Pages 1654-

  Uhlig, Till ^a   Nordvåg, Bjørn Yngvar ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; BIOLOGICAL PRODUCT;

DRUG COST; ECONOMICS; EDITORIAL; HUMAN; PRESCRIPTION; REGISTER; RHEUMATIC DISEASE; STATISTICS; TREATMENT OUTCOME;

ANTIRHEUMATIC AGENTS; BIOLOGICAL PRODUCTS; DRUG COSTS; DRUG PRESCRIPTIONS; HUMANS; REGISTRIES; RHEUMATIC DISEASES; TREATMENT OUTCOME;

EID: 50449090685     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: None     Document Type: Editorial

References (6)

1. Uhlig T, Heiberg T, Mowinckel P et al. Rheumatoid arthritis is milder in the new millennium: Health status in RA patients 1994-2004. Ann Rheum Dis 2008; e-publisert 24.1. 2008.
2. Smolen JS, Aletaha D, Koeller M et al. New therapies for treatment of rheumatoid arthritis. Lancet 2007; 370: 1861-74.
3. Sosial- og helsedirektoratet. Nasjonale faglige retningslinjer for bruk av TNF-α-hemmere og andre biologiske betennelsesdempende legemidler innen revmatologi, gastroenterologi og dermatologi. www.shdir.no/vp/multimedia/ archive/00040/Nasjonale_faglige_re_40309a.pdf (23.6.2008).
4. Kvien TK, Heiberg, Lie E et al. A Norwegian DMARD register: prescriptions of DMARDs and biological agents to patients with inflammatory rheumatic diseases. Clin Exp Rheumatol 2005; 23 (5 suppl 39): 188-94.
5. Dansk Reumatologisk Database. www.danbio-online.dk (20.6.2008).
6. Svenska Reumatologi Register. www.swerre.se (20.6.2008).